Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

High Arctic Energy Gets Necessary Approvals To Conduct Normal Course Issuer Bid

High Arctic Energy Services Inc. (HWO.TO: Quote) said it has made the necessary filings, and received the necessary approvals to conduct a normal course issuer bid through the facilities of the Toronto Stock Exchange.

The TSX has accepted the Corporation's notice to conduct the normal course issuer bid to purchase outstanding common shares on the open market, in accordance with the rules of the TSX. As approved by the TSX, the Corporation is authorized to purchase up to 2.48 million common shares, representing approximately 5% of the currently issued and outstanding common shares of the Corporation.

As of today's date, there are 49.62 million common shares outstanding. On any trading day, High Arctic will not purchase more than 6,248 common shares, other than through block purchase exceptions.

The Corporation is authorized to make purchases during the period from March 23, 2012 to March 22, 2013, or until such earlier time as the normal course issuer bid is completed or terminated at the option of the Corporation.

Click here to receive FREE breaking news email alerts for High Arctic Engy Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Micro-blogging site Twitter Inc said Tuesday after the markets closed that its second quarter loss widened from last year, hurt mainly by stock-based compensation expense, even as revenue more than doubled thanks to growth in advertising. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Pharmaceutical giant Pfizer, Inc., which was aspiring to buy British drug maker AstraZeneca Plc, reported Tuesday a profit for the second quarter that plunged 79 percent from last year, which reflected hefty gains from animal health business sales. Total revenues declined 2 percent, as it continued to be hurt by generic competition for major drugs. Home improvement and building products company Masco Corp. said Monday after the markets closed that its second quarter profit jumped 78% from last year, as revenue increased and margins improved amid strong performance of its Plumbing Products, Installation and Other Services and Decorative Architectural Products segments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.